Johnson & Johnson plans to launch largest-ever coronavirus vaccine trial with up to 60,000 people

Johnson & Johnson is planning to start a late-stage clinical trial of its experimental coronavirus vaccine in up to 60,000 people worldwide in late September. If the company hits the enrollment aim, which was reported on a US government database, it would be the largest-ever study looking at a possible immunization for the virus. Rival … Read more

A coronavirus vaccine could be widely available in the US by APRIL

A coronavirus vaccine could be widely available to much of the American public as early as April of next year, Operation Warp Speed chief Dr Moncef Slaoui told Business Insider in an exclusive interview.  His program aims to have a shot anytime between then and June, which Dr Slaoui believes will make it possible to … Read more

Fewer than half of Americans say they will get a coronavirus vaccine

Less than half of Americans say they will get a coronavirus vaccine when one becomes available, a new survey reveals.  Low rates of willingness to get a potential COVID-19-blocking shot is of concern to public health experts as the US continues to push to reopen, despite more than 30,000 cases being diagnosed a day.  Top … Read more

Coronavirus China: £100 vaccine may be on sale by December

A Chinese Covid-19 vaccine contender may be on the market by December and cost just £100 for two doses. State-owned pharmaceutical company Sinopharm claims the jab could be ready by Christmas, once final stage trials are over. Officials feared the vaccine may not be ready until at least next year because a lack of new infections … Read more

Glimmers of hope for immunity in survivors of mild COVID-19

We’re still at least months away from a coronavirus vaccine – but studies suggest that that millions of people who have recovered from the infection will be  protected against getting it again for at least three months.  Much of the research and discussion of coronavirus immunity has focused on antibodies, with some suggesting these SARS-CoV-2-specific … Read more

Britons will accept local lockdowns if a Covid vaccine can’t be found, survey finds 

Britons will accept local lockdowns, home schooling and bans on live audiences for the foreseeable future if a coronavirus vaccine is not found, a survey suggests. As parts of the UK grapple with local lockdowns, 87 per cent of people said they would accept these being imposed in the future, and 85 per cent said … Read more

Andrew Lloyd Webber volunteers for COVID-19 vaccine study ‘to prove theatres can re-open safely’

Andrew Lloyd Webber volunteers for experimental COVID-19 study working towards a vaccine: ‘I’ll do anything to prove that theatres can re-open safely’ By Kevin Kayhart For Dailymail.com Published: 05:33 BST, 13 August 2020 | Updated: 05:33 BST, 13 August 2020 Andrew Lloyd Webber is walking the talk in the effort to stamp out COVID-19 and … Read more

Vladimir Putin’s coronavirus vaccine ‘was approved after tests on 38 people’

Vladimir Putin’s coronavirus vaccine was waved through after tests on only 38 people and causes side-effects including pain and swelling, according to official paperwork.    The much-trumpeted Russian drug was registered after just 42 days of research, Fontanka news agency says – and its effectiveness is said to be ‘unknown’.  One of the documents submitted for … Read more

Russia’s coronavirus ‘vaccine’ announced – but don’t dismiss it just yet, writes BEN SPENCER 

Russia’s coronavirus ‘vaccine’ announced by Vladimir Putin is shrouded in secrecy – but don’t dismiss it just yet, writes BEN SPENCER By Ben Spencer for the Daily Mail Published: 23:24 BST, 11 August 2020 | Updated: 00:21 BST, 12 August 2020 Russia’s claims to have created the world’s first coronavirus vaccine should not be dismissed … Read more

Top Oxford vaccine scientists in ethics row over whether to infect volunteers with coronavirus

The two British scientists at the forefront of the hunt for a coronavirus vaccine have clashed over a controversial plan to deliberately infect people with the virus. Professor Adrian Hill, director of the Jenner Institute at Oxford University, is in the advanced stages of setting up a human trial for one of the most promising … Read more